1.0200
-0.0300
(-2.86%)
As of 9:16:31 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
87,996
100,244
114,922
113,629
81,283
Operating Income
-87,996
-100,244
-114,922
-113,629
-81,283
Net Non Operating Interest Income Expense
1,385
3,840
1,750
137
19
Pretax Income
-87,204
-96,066
-113,323
-112,839
-82,030
Net Income Common Stockholders
-87,204
-96,066
-113,323
-112,839
-82,030
Diluted NI Available to Com Stockholders
-87,204
-96,066
-113,323
-112,839
-82,030
Basic EPS
-8.62
--
-11.26
-16.01
-18.50
Diluted EPS
-8.62
--
-11.26
-16.01
-18.50
Basic Average Shares
11,150.0870
--
10,061.6150
7,047.2590
4,461.6110
Diluted Average Shares
11,150.0870
--
10,061.6150
7,047.2590
4,461.6110
Total Operating Income as Reported
-88,147
-99,905
-115,073
-114,921
-81,900
Total Expenses
87,996
100,244
114,922
113,629
81,283
Net Income from Continuing & Discontinued Operation
-87,204
-96,066
-113,323
-112,839
-82,030
Normalized Income
-87,204
-96,066
-113,323
-112,839
-82,030
Interest Income
1,393
3,848
2,197
138
20
Interest Expense
8
8
447
1
1
Net Interest Income
1,385
3,840
1,750
137
19
EBIT
-87,196
-96,058
-112,876
-112,838
-82,029
EBITDA
-87,196
-96,058
-112,876
-112,838
-82,029
Net Income from Continuing Operation Net Minority Interest
-87,204
-96,066
-113,323
-112,839
-82,030
Normalized EBITDA
-87,196
-96,058
-112,876
-112,838
-82,029
12/31/2021 - 8/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2X10.DU Abivax SA
5.15
+0.98%
2I9.F Karolinska Development AB (publ)
0.0626
-14.25%
BTTAY Biotest Aktiengesellschaft
24.23
+6.27%
0T20.F Traws Pharma, Inc.
0.0000
-100.00%
5IU.F Isofol Medical AB (publ)
0.1500
+1.56%
6JU0.F BioCardia, Inc.
0.0000
-100.00%
1HB0.F Scorpius Holdings, Inc.
0.0000
-100.00%
6DW.F D. Western Therapeutics Institute, Inc.
0.5550
-5.93%
2DE0.F Genprex, Inc.
0.0000
-100.00%
2KZ0.F Kezar Life Sciences, Inc.
3.5600
-11.00%